The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Cineworld Falls On Warner Streaming Plans

Fri, 04th Dec 2020 10:33

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

BP, up 3.3%. The oil major was the best performing FTSE 100 stock after members of the OPEC+ cartel struck a deal to increase production over the coming months, but by less than anticipated in their previous accord.

----------

SSE, up 3.0%. The Perth, Scotland-based utility is selling a 10% stake in the UK Dogger Bank A and B project to Italian oil major Eni for GBP202.5 million. Eni will buy another 10% stake from Norway's Equinor to have 20% alongside SSE's 40% and Equinor's 40%.

----------

FTSE 100 - LOSERS

----------

Rolls-Royce, down 3.5%. The jet engine maker was the worst-performing blue chip stock, giving back some of this week's bumper gains. It had risen 16% on Thursday as positive vaccine developments boosted the prospects of global travel. The aerospace stock remains up 54% in the past month, though down 46% in the past year.

----------

FTSE 250 - WINNERS

----------

Micro Focus International, up 10%. The software firm was on Thursday touted by Amazon Web Services as one of the businesses that can help companies migrate data to the cloud. AWS noted Micro's deployment environment software which it provided to Kmart Australia.

----------

Premier Oil, up 6.7%. Like BP, the mid-cap oil company's shares rose following Thursday's OPEC+ meeting.

----------

FTSE 250 - LOSERS

----------

Cineworld Group, down 11%. AT&T subsidiary Warner Bros will release its entire 2021 slate of movies on HBO Max streaming and in theatres simultaneously, including "The Matrix 4" and Denis Villeneuve's "Dune" remake, the studio announced in a landmark response to the pandemic Thursday. The "hybrid model" will see films available on HBO Max streaming in the US for one month from the date of their theatrical release.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

N4 Pharma, up 52%. The Chellaston, England-based pharmaceutical company made further gains after it announced on Thursday that cancer drug Nuvec can be freeze dried and stored for 14 day without a significant drop in performance. N4 Pharma said Nuvec formulations which had been freeze dried and then stored for 14 days, either at room temperature or at four degrees celsius, showed no significant drop in in vitro transfection capability following its reconstitution.

----------

Hunters Property, up 44%. The Yorkshire-based estate agent confirmed it received a preliminary approach from Property Franchise Group over a potential takeover offer. Property Franchise shares were down 5.5%.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Petro Matad, down 8.7%. The oil firm said a meeting on the awarding of the Block XX exploitation licence in Mongolia has been postponed due to lockdown measures.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Mar 2021 16:31

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
24 Feb 2021 12:34

N4 Pharma losses widen as it works on commercialising Nuvec

(Sharecast News) - Pre-revenue specialist pharmaceuticals company N4 Pharma reported an operating loss of £1.56m in its final results on Wednesday, widening from the £0.95m loss a year earlier.

Read more
24 Feb 2021 10:25

AIM WINNERS & LOSERS: Mkango Hails Pilot Plant Processing Milestone

AIM WINNERS & LOSERS: Mkango Hails Pilot Plant Processing Milestone

Read more
24 Feb 2021 10:03

N4 Pharma Loss Widens As Ramps Up R&D Investment At "Pivotal Time"

N4 Pharma Loss Widens As Ramps Up R&D Investment At "Pivotal Time"

Read more
11 Feb 2021 11:53

N4 Pharma Shares Jump On European Patent Approval For Nuvec

N4 Pharma Shares Jump On European Patent Approval For Nuvec

Read more
11 Feb 2021 11:21

AIM WINNERS & LOSERS: MediaZest Soars As Kicks Off 2021 With Deal Wins

AIM WINNERS & LOSERS: MediaZest Soars As Kicks Off 2021 With Deal Wins

Read more
9 Dec 2020 14:04

IN BRIEF: N4 Pharma Raises GBP2 Million To Fund Development Work

IN BRIEF: N4 Pharma Raises GBP2 Million To Fund Development Work

Read more
3 Dec 2020 13:39

N4 Pharma shares surge on latest from Nanomerics collaboration

(Sharecast News) - Specialist pharmaceuticals company N4 Pharma updated the market on its ongoing research collaboration agreement with Nanomerics on Thursday.

Read more
3 Dec 2020 10:40

N4 Pharma Shares Soar As Cancer Drug Moves To Phase Two Of Programme

N4 Pharma Shares Soar As Cancer Drug Moves To Phase Two Of Programme

Read more
9 Nov 2020 14:22

N4 Pharma working with Nanomerics on oncology programme

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has appointed Nanomerics to investigate the potential utility of its 'Nuvec' delivery system in cancer therapy.

Read more
9 Nov 2020 14:20

N4 Pharma Plans Nuvec Oncology Treatment Study With UCL's Nanomerics

N4 Pharma Plans Nuvec Oncology Treatment Study With UCL's Nanomerics

Read more
5 Nov 2020 18:07

UK TRADING UPDATE SUMMARY: Zotefoams Hails Record Third Quarter Sales

UK TRADING UPDATE SUMMARY: Zotefoams Hails Record Third Quarter Sales

Read more
17 Sep 2020 14:36

IN BRIEF: N4 Pharma Pretax Loss Widens; Aims To Maximise Nuvec Uses

IN BRIEF: N4 Pharma Pretax Loss Widens; Aims To Maximise Nuvec Uses

Read more
14 Sep 2020 10:52

N4 Pharma Plunges 40% As Covid-19 Antibody Delivery Study Disappoints

N4 Pharma Plunges 40% As Covid-19 Antibody Delivery Study Disappoints

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.